Substituted imidazoles as tafia inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 233/64 (2006.01) A61K 31/00 (2006.01) A61K 31/415 (2006.01) A61K 31/4172 (2006.01) A61P 7/02 (2006.01) C07D 233/54 (2006.01) C07D 401/06 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 417/06 (2006.01)

Patent

CA 2419633

The present invention provides compounds of formula (I). These compounds are a class of TAFIa inhibitors, which may be used in treating or preventing atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases and those conditions which benefit from maintaining or enhancing bradykinin levels in the body.

La présente invention concerne des composés de formule (I), qui sont une classe d'inhibiteurs TAFIa (Activate Thrombin activatable Fibrinolysis Inhibitor) particulièrement utilisés dans le traitement d'états pathologiques tels que l'athérosclérose, les adhérences, la cicatrisation dermique, le cancer, les états fibreux, les maladies fibreuses et tous les états qui peuvent bénéficier du maintien ou de l'augmentation des taux de bradykinine dans le corps.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Substituted imidazoles as tafia inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted imidazoles as tafia inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazoles as tafia inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1729531

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.